{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:03:20Z","timestamp":1790269400505,"version":"4.1.0"},"reference-count":184,"publisher":"Elsevier","isbn-type":[{"value":"9780443472169","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.08.009","type":"book-chapter","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:34:54Z","timestamp":1787574894000},"page":"345-402","source":"Crossref","is-referenced-by-count":0,"title":["Silent clues in blood: Proteomic approach for Alzheimer\u2019s disease"],"prefix":"10.1016","author":[{"given":"Adriele Rebeca Vieira","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Santos Vieira","family":"da Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Mariana da Silva","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michely da Silva","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemmyson Rom\u00e1rio","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00edcero Alves","family":"Lopes J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/bs.irn.2026.08.009_bib1","article-title":"Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer\u2019s disease","volume":"12","author":"Abbas","year":"2025","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-025-08186-8","article-title":"Amyloid-\u03b2 and Tau in Alzheimer\u2019s disease: Pathogenesis, mechanisms, and interplay","volume":"17","author":"Abdulkhaliq","year":"2026","journal-title":"Cell Death & Disease"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.009_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70276","article-title":"LC-MS\/MS proteomics identifies plasma proteins related to cognition over 9-year follow-up","volume":"21","author":"Adegboye","year":"2025","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"10.1016\/bs.irn.2026.08.009_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmsacl.2025.10.001","article-title":"Tear fluid proteomics: A comparative study of DIA and DDA mass spectrometry","volume":"38","author":"Ahmed","year":"2025","journal-title":"Journal of Mass Spectrometry and Advances in the Clinical Lab"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13041-022-00937-4","article-title":"Blood\u2013brain barrier: Emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders","volume":"15","author":"Alajangi","year":"2022","journal-title":"Molecular Brain"},{"issue":"22","key":"10.1016\/bs.irn.2026.08.009_bib6","doi-asserted-by":"crossref","first-page":"16288","DOI":"10.3390\/ijms242216288","article-title":"Blood\u2013Brain barrier breakdown in Alzheimer\u2019s disease: Mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.009_bib7","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/pr3001546","article-title":"Label-free quantitative LC\u2013MS proteomics of Alzheimer\u2019s disease and normally aged human brains","volume":"11","author":"Andreev","year":"2012","journal-title":"Journal of Proteome Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-anchem-061516-045357","article-title":"Relative and absolute quantitation in mass spectrometry\u2013based proteomics","volume":"11","author":"Ankney","year":"2018","journal-title":"Annual Review of Analytical Chemistry"},{"key":"10.1016\/bs.irn.2026.08.009_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelechem.2025.119281","article-title":"A label-free electrochemical immunosensor based on MWCNT-COOH\/dPEDOT for early detection of Alzheimer\u2019s disease biomarker p-Tau 217","volume":"992","author":"Ariyasajjamongkol","year":"2025","journal-title":"Journal of Electroanalytical Chemistry"},{"key":"10.1016\/bs.irn.2026.08.009_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103836","article-title":"Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer\u2019s disease","volume":"76","author":"Ashton","year":"2022","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.009_bib11","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nature Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.009_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: A new biomarker for incipient Alzheimer\u2019s disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-021-00474-z","article-title":"Proteomic landscape of Alzheimer\u2019s disease: Novel insights into pathogenesis and biomarker discovery","volume":"16","author":"Bai","year":"2021","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.irn.2026.08.009_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2017.06.297","article-title":"[P1\u2013281]: Diagnostic performance using CSF YKL\u201040 IN Alzheimer\u2019s disease and frontotemporal dementia","volume":"13","author":"Baldacci","year":"2017","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.009_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jalz.2017.01.021","article-title":"Two\u2010level diagnostic classification using cerebrospinal fluid YKL\u201040 in Alzheimer\u2019s disease","volume":"13","author":"Baldacci","year":"2017","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"11","key":"10.1016\/bs.irn.2026.08.009_bib16","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.009_bib17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41635","article-title":"Clusterin induced by OPC phagocytosis blocks IL-9 secretion to inhibit myelination in a model of Alzheimer\u2019s disease","volume":"11","author":"Beiter","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/bs.irn.2026.08.009_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.107234","article-title":"Cerebrospinal fluid \u03b1-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer\u2019s disease","volume":"218","author":"Bellomo","year":"2026","journal-title":"Neurobiology of Disease"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.009_bib20","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.irn.2026.08.009_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2025.12.005","article-title":"Diagnostic performance of plasma pTau217\/A\u03b242 ratio and a three-zone threshold model for Alzheimer\u2019s disease","volume":"159","author":"Benussi","year":"2026","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1021\/acs.jproteome.4c00837","article-title":"IP-to-MS: An unbiased workflow for antigen profiling","volume":"24","author":"Biedka","year":"2025","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2026.08.009_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462299","article-title":"Development of immunoprecipitation \u2013 two-dimensional liquid chromatography \u2013 mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients","volume":"1651","author":"Bijttebier","year":"2021","journal-title":"Journal of Chromatography. A"},{"issue":"10","key":"10.1016\/bs.irn.2026.08.009_bib24","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1002\/alz.13157","article-title":"Longitudinal changes in Alzheimer\u2019s-related plasma biomarkers and brain amyloid","volume":"19","author":"Bilgel","year":"2023","journal-title":"Alzheimer\u2019s and Dementia"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12014-023-09424-x","article-title":"Mass spectrometry-based proteomics as an emerging tool in clinical laboratories","volume":"20","author":"Birhanu","year":"2023","journal-title":"Clinical Proteomics"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13195-023-01304-8","article-title":"Systematic review: Fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer\u2019s disease","volume":"15","author":"Blanco","year":"2023","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-022-01118-0","article-title":"Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer\u2019s disease: Results from the DELCODE study","volume":"15","author":"Brosseron","year":"2023","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.009_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22052761","article-title":"Machine learning and novel biomarkers for the diagnosis of Alzheimer\u2019s disease","volume":"22","author":"Chang","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.009_bib29","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimer\u2019s and Dementia"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Translational Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib31","article-title":"A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer\u2019s disease","volume":"13","author":"Chen","year":"2026","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"35","key":"10.1016\/bs.irn.2026.08.009_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202510061","article-title":"Artificial intelligence\u2010driven proteomics identifies plasma protein signatures for diagnosis and stratification of Beh\u00e7et\u2019s disease","volume":"12","author":"Cheng","year":"2025","journal-title":"Advanced Science"},{"key":"10.1016\/bs.irn.2026.08.009_bib33","first-page":"1","article-title":"Cytoskeletal proteins regulates Tau protein in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2026","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.009_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bnd.2024.12.006","article-title":"Neuron-derived extracellular vesicle-based diagnostics for Tau and Alzheimer\u2019s disease","volume":"1","author":"Chinnathambi","year":"2025","journal-title":"Brain Network Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.009_bib36","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/alz.12233","article-title":"ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration","volume":"17","author":"Cousins","year":"2021","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"10","key":"10.1016\/bs.irn.2026.08.009_bib37","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: A novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease","volume":"68","author":"Craig-Schapiro","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13195-024-01612-7","article-title":"Glymphatic system clearance and Alzheimer\u2019s disease risk: a CSF proteome-wide study","volume":"17","author":"Cullell","year":"2025","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/bs.irn.2026.08.009_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-030-05542-4_2","article-title":"The role of biomarkers in Alzheimer\u2019s disease drug development","author":"Cummings","year":"2019","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/bs.irn.2026.08.009_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.128387","article-title":"Investigating the inhibitory effect of gold nanoparticles with different diameters on the aggregation behavior of A\u03b240 and A\u03b242 peptides involved in Alzheimer\u2019s disease using molecular dynamics simulations","volume":"437","author":"Daei","year":"2025","journal-title":"Journal of Molecular Liquids"},{"key":"10.1016\/bs.irn.2026.08.009_bib41","article-title":"The glymphatic system clears amyloid beta and tau from brain to plasma in humans","author":"Dagum","year":"2024","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13195-024-01459-y","article-title":"Alzheimer\u2019s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline","volume":"16","author":"Dark","year":"2024","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.009_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/arclin\/acae019","article-title":"Plasma biomarkers for Alzheimer\u2019s and related dementias: A review and outlook for clinical neuropsychology","volume":"39","author":"Dark","year":"2024","journal-title":"Archives of Clinical Neuropsychology"},{"key":"10.1016\/bs.irn.2026.08.009_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106263","article-title":"Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models","volume":"186","author":"Das","year":"2023","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.irn.2026.08.009_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.00265","article-title":"Mechanisms of pathogenic tau and A\u03b2 protein spreading in Alzheimer\u2019s disease","volume":"12","author":"d\u2018Errico","year":"2020","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12014-019-9237-1","article-title":"Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer\u2019s disease","volume":"16","author":"Dey","year":"2019","journal-title":"Clinical Proteomics"},{"key":"10.1016\/bs.irn.2026.08.009_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.117087","article-title":"Recent advances in electrochemical biosensors for the detection of A\u03b242, a biomarker for Alzheimer disease diagnosis","volume":"164","author":"Ding","year":"2023","journal-title":"TrAC Trends in Analytical Chemistry"},{"issue":"15","key":"10.1016\/bs.irn.2026.08.009_bib48","doi-asserted-by":"crossref","first-page":"E1580","DOI":"10.1212\/WNL.0000000000009240","article-title":"Total A\u03b242\/A\u03b240 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis","volume":"94","author":"Doecke","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2026.08.009_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.125529","article-title":"Advances in single molecule arrays (SIMOA) for ultra-sensitive detection of biomolecules","volume":"270","author":"Dong","year":"2024","journal-title":"Talanta"},{"issue":"52","key":"10.1016\/bs.irn.2026.08.009_bib50","doi-asserted-by":"crossref","first-page":"18213","DOI":"10.1074\/jbc.RA120.015882","article-title":"A combinatorial native MS and LC-MS\/MS approach reveals high intrinsic phosphorylation of human tau but minimal levels of other key modifications","volume":"295","author":"Drepper","year":"2020","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.009_bib51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","article-title":"Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer\u2019s disease","volume":"16","author":"Elahi","year":"2020","journal-title":"Alzheimer\u2019s and Dementia"},{"issue":"9\u201310","key":"10.1016\/bs.irn.2026.08.009_bib52","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1023\/A:1007677003387","article-title":"Glial fibrillary acidic protein: GFAP-thirty-one years (1969\u20132000)","volume":"25","author":"Eng","year":"2000","journal-title":"Neurochemical Research"},{"key":"10.1016\/bs.irn.2026.08.009_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101111","article-title":"CD33 isoforms in microglia and Alzheimer\u2019s disease: Friend and foe","volume":"90","author":"Eskandari-Sedighi","year":"2023","journal-title":"Molecular Aspects of Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.009_bib54","volume":"13","author":"Fandos","year":"2026","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.08.009_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2026.102874","article-title":"An anti-inflammatory neuroenhancer mitigates amyloid-\u03b2 pathology to improve Alzheimer\u2019s disease therapy","volume":"37","author":"Fang","year":"2026","journal-title":"Materials Today Bio"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.009_bib56","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jsps.2023.05.013","article-title":"Plasma levels of phosphorylated tau and neurofilament light chain as potential biomarkers for Alzheimer\u2019s disease: A biochemical analysis in Pakistani population","volume":"31","author":"Faraz Ahmed","year":"2023","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.009_bib57","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1021\/acs.jproteome.0c00153","article-title":"Impact of the Identification Strategy on the Reproducibility of the DDA and DIA Results","volume":"19","author":"Fern\u00e1ndez-Costa","year":"2020","journal-title":"Journal of Proteome Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib58","first-page":"730","article-title":"The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer\u2019s disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta\u2010analysis","volume":"11","author":"Forgrave","year":"2019","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/bs.irn.2026.08.009_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117842","article-title":"New approach for early and specific Alzheimer disease diagnosis from different plasma biomarkers","volume":"556","author":"Forte","year":"2024","journal-title":"Clinica Chimica Acta"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.009_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70104","article-title":"Biomarkers of blood\u2013brain barrier and neurovascular unit integrity in human cognitive impairment and dementia","volume":"21","author":"French","year":"2025","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.009_bib61","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/brain\/awaa098","article-title":"Neurofilaments: Neurobiological foundations for biomarker applications","volume":"143","author":"Gafson","year":"2020","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2026.08.009_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/alz70862_110859","article-title":"Plasma proteomics reveals novel protein signatures associated with dementia in chronic pain individuals: A prospective cohort study","volume":"21","author":"Gao","year":"2025","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/bs.irn.2026.08.009_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.125597","article-title":"Label-free electrochemical immunosensing of glial fibrillary acidic protein (GFAP) at synthesized rGO\/MoS2\/AgNPs nanocomposite. Application to the determination in human cerebrospinal fluid","volume":"270","author":"Garc\u00eda-Rodrigo","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/bs.irn.2026.08.009_bib64","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ibneur.2025.04.016","article-title":"Bridging neuro-biomarkers and MR imaging: The synergistic role of glial fibrillary acidic protein in early CNS disease diagnosis","volume":"18","author":"Ghaderian","year":"2025","journal-title":"IBRO Neuroscience Reports"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.009_bib65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jagp.2024.09.015","article-title":"Where do plasma biomarkers fit in with current Alzheimer\u2019s disease detection?","volume":"33","author":"Gildengers","year":"2025","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.009_bib66","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00424-014-1471-9","article-title":"Proteomics in heart failure: Top-down or bottom-up?","volume":"466","author":"Gregorich","year":"2014","journal-title":"Pfl\u00fcgers Archiv - European Journal of Physiology"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41398-022-02205-4","article-title":"Peripheral level of CD33 and Alzheimer\u2019s disease: A bidirectional two-sample Mendelian randomization study","volume":"12","author":"Gu","year":"2022","journal-title":"Translational Psychiatry"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.009_bib68","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.3390\/ijms23094962","article-title":"Biomarkers for Alzheimer\u2019s disease in the current state: A narrative review","volume":"23","author":"Gunes","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13195-023-01174-0","article-title":"The dynamics of plasma biomarkers across the Alzheimer\u2019s continuum","volume":"15","author":"Guo","year":"2023","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.009_bib70","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nature Reviews Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.009_bib71","doi-asserted-by":"crossref","first-page":"401","DOI":"10.37349\/ent.2024.00091","article-title":"Impaired glymphatic clearance is an important cause of Alzheimer\u2019s disease","volume":"4","author":"Hazzard","year":"2024","journal-title":"Exploration of Neuroprotective Therapy"},{"key":"10.1016\/bs.irn.2026.08.009_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbas.2024.100134","article-title":"TOMM40 may mediate GFAP, neurofilament light Protein, pTau181, and brain morphometry in aging","volume":"7","author":"Honea","year":"2025","journal-title":"Aging Brain"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib73","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/acn3.70227","article-title":"Plasma proteomic signatures for Alzheimer\u2019s disease: Comparable accuracy to ATN biomarkers and cross-platform validation","volume":"13","author":"Hu","year":"2025","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"10.1016\/bs.irn.2026.08.009_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150768","article-title":"Expressing miR-282 mitigates A\u03b242-induced neurodegeneration in Alzheimer\u2019s model in Drosophila","volume":"734","author":"Huang","year":"2024","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"17","key":"10.1016\/bs.irn.2026.08.009_bib75","doi-asserted-by":"crossref","first-page":"13064","DOI":"10.3390\/ijms241713064","article-title":"Identification of plasma proteins as biomarkers for mild cognitive impairment and Alzheimer\u2019s disease using liquid chromatography\u2013tandem mass spectrometry","volume":"24","author":"Inoue","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12987-025-00634-z","article-title":"Applying machine learning to high-dimensional proteomics datasets for the identification of Alzheimer\u2019s disease biomarkers","volume":"22","author":"Ivarsson Orrelid","year":"2025","journal-title":"Fluids and Barriers of the CNS"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib77","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nature Communications"},{"issue":"11","key":"10.1016\/bs.irn.2026.08.009_bib78","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14526","article-title":"Differential roles of Alzheimer\u2019s disease plasma biomarkers in stepwise biomarker-guided diagnostics","volume":"21","author":"Jang","year":"2025","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"10.1016\/bs.irn.2026.08.009_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103142","article-title":"Development and validation of machine learning models with blood-based digital biomarkers for Alzheimer\u2019s disease diagnosis: A multicohort diagnostic study","volume":"81","author":"Jiao","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.009_bib81","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/brain\/awac399","article-title":"Plasma biomarker profiles in autosomal dominant Alzheimer\u2019s disease","volume":"146","author":"Johansson","year":"2023","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib82","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad057","article-title":"Plasma phosphorylated tau 217 in preclinical Alzheimer\u2019s disease","volume":"5","author":"Jonaitis","year":"2023","journal-title":"Brain Communications"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib83","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13195-022-01011-w","article-title":"Diagnostic value of serum versus plasma phospho-tau for Alzheimer\u2019s disease","volume":"14","author":"Kac","year":"2022","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/bs.irn.2026.08.009_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102497","article-title":"AI-driven innovations in Alzheimer\u2019s disease: Integrating early diagnosis, personalized treatment, and prognostic modelling","volume":"101","author":"Kale","year":"2024","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/bs.irn.2026.08.009_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Research Reviews"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.009_bib86","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: A diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.009_bib87","doi-asserted-by":"crossref","DOI":"10.1214\/10-AOAS341","article-title":"Liquid chromatography mass spectrometry-based proteomics: Biological and technological aspects","volume":"4","author":"Karpievitch","year":"2010","journal-title":"The Annals of Applied Statistics"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.009_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.101465","article-title":"Properties, origin, and consistency of truncated proteoforms across top-down proteomic studies","volume":"24","author":"Kaulich","year":"2025","journal-title":"Molecular & Cellular Proteomics: MCP"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.009_bib89","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41592-024-02481-6","article-title":"Influence of different sample preparation approaches on proteoform identification by top-down proteomics","volume":"21","author":"Kaulich","year":"2024","journal-title":"Nature Methods"},{"issue":"24","key":"10.1016\/bs.irn.2026.08.009_bib90","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/pmic.202400338","article-title":"Top-down proteomics: Why and when?","volume":"25","author":"Kaulich","year":"2025","journal-title":"Proteomics"},{"issue":"23","key":"10.1016\/bs.irn.2026.08.009_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235932","article-title":"Optimization of data-independent acquisition mass spectrometry for deep and highly sensitive proteomic analysis","volume":"20","author":"Kawashima","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib92","first-page":"575","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/bs.irn.2026.08.009_bib93","article-title":"Lysine-directed post-translational modifications of tau protein in Alzheimer\u2019s disease and related tauopathies","volume":"4","author":"Kontaxi","year":"2017"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib94","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/19336896.2021.1917289","article-title":"Development of molecular tools for diagnosis of Alzheimer\u2019s disease that are based on detection of amyloidogenic proteins","volume":"15","author":"Kulichikhin","year":"2021","journal-title":"Prion"},{"key":"10.1016\/bs.irn.2026.08.009_bib95","article-title":"Identification of novel biomarkers for Alzheimer\u2019s disease and related dementias using unbiased plasma proteomics","author":"Lacar","year":"2024","journal-title":"BioRxiv: The Preprint Server for Biology"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.009_bib96","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae396","article-title":"Glial fibrillary acidic protein in Alzheimer\u2019s disease: A narrative review","volume":"6","author":"Leipp","year":"2024","journal-title":"Brain Communications"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib97","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114408","article-title":"Blood\u2010based biomarkers for Alzheimer\u2019s disease","volume":"14","author":"Leuzy","year":"2022","journal-title":"EMBO Molecular Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib98","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-160722","article-title":"Cerebrospinal fluid A\u03b242\/40 corresponds better than A\u03b242 to amyloid PET in Alzheimer\u2019s disease","volume":"55","author":"Lewczuk","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib99","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40120-019-00164-5","article-title":"An update on blood-based markers of Alzheimer\u2019s disease using the SiMoA platform","volume":"8","author":"Li","year":"2019","journal-title":"Neurology and Therapy"},{"issue":"18","key":"10.1016\/bs.irn.2026.08.009_bib100","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1021\/acschemneuro.5c00301","article-title":"Development of new blood immunoassay and biomarkers for tau in the diagnosis of Alzheimer\u2019s disease","volume":"16","author":"Li","year":"2025","journal-title":"ACS Chemical Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.009_bib101","doi-asserted-by":"crossref","first-page":"E688","DOI":"10.1212\/WNL.0000000000013211","article-title":"Validation of plasma amyloid-\u03b2 42\/40 for detecting Alzheimer disease amyloid plaques","volume":"98","author":"Li","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2026.08.009_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2026.103165","article-title":"Decoding Alzheimer\u2019s genetic risk through intercellular communication in the human brain: Lessons from clusterin","volume":"97","author":"Lish","year":"2026","journal-title":"Current Opinion in Neurobiology"},{"issue":"10452","key":"10.1016\/bs.irn.2026.08.009_bib103","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the lancet standing commission","volume":"404","author":"Livingston","year":"2024","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100712","article-title":"Acquisition and analysis of DIA-based proteomic data: A comprehensive survey in 2023","volume":"23","author":"Lou","year":"2024","journal-title":"Molecular and Cellular Proteomics"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.009_bib105","doi-asserted-by":"crossref","first-page":"MSB178126","DOI":"10.15252\/msb.20178126","article-title":"Data\u2010independent acquisition\u2010based SWATH \u2010 MS for quantitative proteomics: A tutorial","volume":"14","author":"Ludwig","year":"2018","journal-title":"Molecular Systems Biology"},{"issue":"21","key":"10.1016\/bs.irn.2026.08.009_bib106","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1007\/s00216-020-02540-9","article-title":"New trends in single-molecule bioanalytical detection","volume":"412","author":"Macchia","year":"2020","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/bs.irn.2026.08.009_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1254834","article-title":"Comparative assessment of Alzheimer\u2019s disease-related biomarkers in plasma and neuron-derived extracellular vesicles: A nested case-control study","volume":"10","author":"Manolopoulos","year":"2023","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10.1016\/bs.irn.2026.08.009_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148812","article-title":"Present and future of blood-based biomarkers of Alzheimer\u2019s disease: Beyond the classics","volume":"1830","author":"Mantellatto Grigoli","year":"2024","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.neumar.2025.100038","article-title":"Glial fibrillary acidic protein as a biomarker for diagnosis of Alzheimer\u2019s disease in cerebrospinal fluid, plasma and saliva measured with Lumipulse technology: A narrative review","volume":"2","author":"Marksteiner","year":"2025","journal-title":"NeuroMarkers"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.009_bib110","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.009_bib111","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s10072-023-07065-4","article-title":"The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment","volume":"45","author":"Mazzeo","year":"2023","journal-title":"Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib112","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41597-023-02057-7","article-title":"A peptide-centric quantitative proteomics dataset for the phenotypic assessment of Alzheimer\u2019s disease","volume":"10","author":"Merrihew","year":"2023","journal-title":"Scientific Data"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.009_bib113","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3233\/JAD-220523","article-title":"Biomarkers of inflammation increase with tau and neurodegeneration but not with amyloid-\u03b2 in a heterogenous clinical cohort","volume":"89","author":"Michopoulou","year":"2022","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.009_bib114","first-page":"1797","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease","volume":"28","author":"Mil\u00e0-Alom\u00e0","year":"2022","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.009_bib115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1039\/D2AN01246D","article-title":"Overview and considerations in bottom-up proteomics","volume":"148","author":"Miller","year":"2023","journal-title":"Analyst"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib116","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-023-01173-1","article-title":"Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer\u2019s disease continuum: Biological and methodological perspectives from disease heterogeneity","volume":"15","author":"Mohanty","year":"2023","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib117","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13195-024-01647-w","article-title":"Blood-based biomarkers and plasma A\u03b2 assays in the differential diagnosis of Alzheimer\u2019s disease and behavioral-variant frontotemporal dementia","volume":"16","author":"Mohaupt","year":"2024","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.009_bib118","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"10","key":"10.1016\/bs.irn.2026.08.009_bib119","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/acn3.51863","article-title":"A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment","volume":"10","author":"Monane","year":"2023","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"10.1016\/bs.irn.2026.08.009_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123679","article-title":"Serum neurofilament light chain levels are associated with cognitive decline in a consecutive cohort of patients with Alzheimer\u2019s disease","volume":"477","author":"Musaeus","year":"2025","journal-title":"Journal of the Neurological Sciences"},{"issue":"7691","key":"10.1016\/bs.irn.2026.08.009_bib121","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2026.08.009_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123562","article-title":"Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis","volume":"475","author":"Novarella","year":"2025","journal-title":"Journal of the Neurological Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib123","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.009_bib124","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1038\/s41591-025-03798-1","article-title":"Plasma proteomics links brain and immune system aging with healthspan and longevity","volume":"31","author":"Oh","year":"2025","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.irn.2026.08.009_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.125736","article-title":"Phospho-Tau 181 quantification method for Alzheimer\u2019s disease based on an array 2D biosensor combined with surface plasmon resonance imaging","volume":"271","author":"Oldak","year":"2024","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib126","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/ADR-230029","article-title":"Plasma biomarkers of Alzheimer\u2019s disease: A review of available assays, recent developments, and implications for clinical practice","volume":"7","author":"Pais","year":"2023","journal-title":"Journal of Alzheimer\u2019s Disease Reports"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.009_bib127","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Molecular Medicine"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.009_bib128","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA: the Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s43856-023-00295-9","article-title":"Integrated algorithm combining plasma biomarkers and cognitive assessments accurately predicts brain \u03b2-amyloid pathology","volume":"3","author":"Pan","year":"2023","journal-title":"Communications Medicine"},{"key":"10.1016\/bs.irn.2026.08.009_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676621","article-title":"Immune response in neurological pathology: Emerging role of central and peripheral immune crosstalk","volume":"12","author":"Passaro","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.irn.2026.08.009_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120397","article-title":"Emerging blood biomarkers in Alzheimer\u2019s disease: A proteomic perspective","volume":"576","author":"Patel","year":"2025","journal-title":"Clinica Chimica Acta"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.009_bib132","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1021\/acs.jproteome.5c00513","article-title":"Plasma proteomic analysis for Alzheimer\u2019s disease biomarkers, pathways, and subgroup identification","volume":"24","author":"Pe\u00f1a-Bautista","year":"2025","journal-title":"Journal of Proteome Research"},{"issue":"11","key":"10.1016\/bs.irn.2026.08.009_bib133","doi-asserted-by":"crossref","first-page":"2657.e1","DOI":"10.1016\/j.neurobiolaging.2014.06.005","article-title":"Novel APP K724M mutation causes Chinese early-onset familial Alzheimer\u2019s disease and increases amyloid-\u03b242 to amyloid-\u03b240 ratio","volume":"35","author":"Peng","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib134","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuron.2025.09.032","article-title":"The gain-of-function TREM2-T96K mutation increases risk for Alzheimer\u2019s disease by impairing microglial function","volume":"114","author":"Pilat","year":"2026","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.irn.2026.08.009_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1028448","article-title":"Integration of amyloid-\u03b2 oligomerization tendency as a plasma biomarker in Alzheimer\u2019s disease diagnosis","volume":"13","author":"Pyun","year":"2023","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/bs.irn.2026.08.009_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106096","article-title":"Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe disease","volume":"123","author":"Regmi","year":"2026","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.irn.2026.08.009_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100155","article-title":"Uncovering the depths of the human proteome: Antibody-based technologies for ultrasensitive multiplexed protein detection and quantification","volume":"20","author":"Ren","year":"2021","journal-title":"Molecular and Cellular Proteomics"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib139","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s43586-024-00318-2","article-title":"Top-down proteomics","volume":"4","author":"Roberts","year":"2024","journal-title":"Nature Reviews Methods Primers"},{"issue":"26","key":"10.1016\/bs.irn.2026.08.009_bib140","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.36414\/rbmc.v12i26.211","article-title":"Biomarcadores para diagn\u00f3stico e progn\u00f3stico de Alzheimer","volume":"12","author":"Rodrigues","year":"2026","journal-title":"Revista Brasileira Militar De Ci\u00eancias"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.009_bib141","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.neuron.2025.11.022","article-title":"The Alzheimer\u2019s disease risk genes MS4A4A and MS4A6A cooperate to negatively regulate TREM2 and microglia states","volume":"114","author":"Rosner","year":"2026","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2026.08.009_bib142","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ibneur.2025.04.018","article-title":"Potential mediating role of polygenic hazard score in the association between neurofilament light chain and default mode network connectivity across the Alzheimer\u2019s disease continuum","volume":"18","author":"Saberian","year":"2025","journal-title":"IBRO Neuroscience Reports"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.009_bib143","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1021\/acs.jproteome.0c00332","article-title":"Improving proteoform identifications in complex systems through integration of bottom-up and top-down data","volume":"19","author":"Schaffer","year":"2020","journal-title":"Journal of Proteome Research"},{"issue":"17","key":"10.1016\/bs.irn.2026.08.009_bib144","doi-asserted-by":"crossref","first-page":"E1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2026.08.009_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.07.013","article-title":"Challenges in the practical implementation of blood biomarkers for Alzheimer\u2019s disease","volume":"5","author":"Sch\u00f6ll","year":"2024","journal-title":"The Lancet Healthy Longevity"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.009_bib146","doi-asserted-by":"crossref","first-page":"a005777","DOI":"10.1101\/cshperspect.a005777","article-title":"Synapses and Alzheimer\u2019s disease","volume":"4","author":"Sheng","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.irn.2026.08.009_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.712545","article-title":"Plasma proteomic biomarkers relating to Alzheimer\u2019s disease: A meta-analysis based on our own studies","volume":"13","author":"Shi","year":"2021","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.009_bib148","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/ene.15762","article-title":"Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia","volume":"30","author":"Silva\u2010Sp\u00ednola","year":"2023","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.009_bib149","article-title":"Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness","volume":"15","author":"Simonsen","year":"2023","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.009_bib150","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41587-023-01714-x","article-title":"Global detection of human variants and isoforms by deep proteome sequencing","volume":"41","author":"Sinitcyn","year":"2023","journal-title":"Nature Biotechnology"},{"issue":"10","key":"10.1016\/bs.irn.2026.08.009_bib151","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.54.10.1960","article-title":"Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD","volume":"54","author":"Sj\u00f6gren","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2026.08.009_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106175","article-title":"Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer\u2019s disease","volume":"183","author":"Snellman","year":"2023","journal-title":"Neurobiology of Disease"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.009_bib153","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201900029","article-title":"Targeted and untargeted proteomics approaches in biomarker development","volume":"20","author":"Sobsey","year":"2020","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib154","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210225","article-title":"Blood-based biomarkers and risk of onset of mild cognitive impairment over the short and long term","volume":"104","author":"Soldan","year":"2025","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib155","first-page":"27","article-title":"Plasma protein panel for assessing the risk of Alzheimer\u2019s disease by MRM-MS analysis: The study of two independent clinical cohorts","volume":"27","author":"Strelnikova","year":"2025","journal-title":"International Journal of Molecular Sciences 2026"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.009_bib156","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.3390\/ijms24043970","article-title":"Specific mutations near the amyloid precursor protein cleavage site increase \u03b3-secretase sensitivity and modulate amyloid-\u03b2 production","volume":"24","author":"Suzuki","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.009_bib157","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/omi.2013.0017","article-title":"Application of machine learning to proteomics data: Classification and biomarker identification in postgenomics biology","volume":"17","author":"Swan","year":"2013","journal-title":"OMICS A Journal of Integrative Biology"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.009_bib158","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/pmic.201000548","article-title":"Mass spectrometry-based immuno-precipitation proteomics - The user\u2019s guide","volume":"11","author":"Ten Have","year":"2011","journal-title":"Proteomics"},{"issue":"10","key":"10.1016\/bs.irn.2026.08.009_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100629","article-title":"Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias","volume":"22","author":"Teunissen","year":"2023","journal-title":"Molecular & Cellular Proteomics"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"The Lancet Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.009_bib161","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: A retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib162","doi-asserted-by":"crossref","first-page":"9736","DOI":"10.1038\/s41598-021-89004-x","article-title":"Highly specific and ultrasensitive plasma test detects Abeta(1\u201342) and Abeta(1\u201340) in Alzheimer\u2019s disease","volume":"11","author":"Thijssen","year":"2021","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib163","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13281","article-title":"Brain and plasmatic clusterin\u00a0are translational markers of Alzheimer\u2019s\u00a0disease","volume":"35","author":"Tournier","year":"2025","journal-title":"Brain Pathology"},{"issue":"10","key":"10.1016\/bs.irn.2026.08.009_bib164","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1021\/pr100646w","article-title":"Depletion of abundant plasma proteins and limitations of plasma proteomics","volume":"9","author":"Tu","year":"2010","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2026.08.009_bib165","series-title":"E-Books principles of proteomics download PDF book details","author":"Twyman","year":"2013"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib166","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66728-2","article-title":"Blood biomarkers of Alzheimer\u2019s disease and progression across different stages of cognitive decline in the community","volume":"16","author":"Valletta","year":"2025","journal-title":"Nature Communications"},{"issue":"20","key":"10.1016\/bs.irn.2026.08.009_bib167","doi-asserted-by":"crossref","first-page":"23102","DOI":"10.1021\/acsami.1c22734","article-title":"Highly specific protein identification by immunoprecipitation\u2013mass spectrometry using antifouling microbeads","volume":"14","author":"Van Andel","year":"2022","journal-title":"ACS Applied Materials & Interfaces"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.009_bib168","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/cells11081367","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease diagnosis and progression: An overview","volume":"11","author":"Varesi","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib169","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta(1-42\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/bs.irn.2026.08.009_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134658","article-title":"Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer\u2019s disease","volume":"715","author":"Wang","year":"2020","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2026.08.009_bib171","article-title":"Association of soluble TREM2 with Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2024","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib172","first-page":"007","article-title":"Is beta-amyloid accumulation a cause or consequence of Alzheimer\u2019s disease?","volume":"1","author":"Wang","year":"2016","journal-title":"Journal of Alzheimer\u2019s Parkinsonism & Dementia"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib173","first-page":"103","article-title":"Plasma clusterin levels and risk of dementia, Alzheimer\u2019s disease, and stroke","volume":"3","author":"Weinstein","year":"2016","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib174","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12014-024-09452-1","article-title":"Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers","volume":"21","author":"Wenk","year":"2024","journal-title":"Clinical Proteomics"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.009_bib175","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","article-title":"Tau PTM profiles identify patient heterogeneity and stages of Alzheimer\u2019s disease","volume":"183","author":"Wesseling","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.009_bib176","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1515\/cclm-2023-0659","article-title":"CSF and plasma A\u03b242\/40 across Alzheimer s disease continuum: Comparison of two ultrasensitive Simoa\u00ae assays targeting distinct amyloid regions","volume":"62","author":"Wojdalaa","year":"2024","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/bs.irn.2026.08.009_bib177","doi-asserted-by":"crossref","first-page":"419","DOI":"10.12688\/f1000research.7042.1","article-title":"Technical advances in proteomics: New developments in data-independent acquisition","volume":"5","author":"Wolf-Yadlin","year":"2016","journal-title":"F1000Research"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.009_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.101003","article-title":"Recent advances in mass spectrometry-based studies of post-translational modifications in Alzheimer\u2019s disease","volume":"24","author":"Wu","year":"2025","journal-title":"Molecular & Cellular Proteomics"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib179","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-025-00874-5","article-title":"Proteomic landscape of Alzheimer\u2019s disease: Emerging technologies, advances and insights (2021 \u2013 2025)","volume":"20","author":"Yarbro","year":"2025","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13195-021-00862-z","article-title":"Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer\u2019s disease by meta-analysis and adaptive boosting ensemble learning","volume":"13","author":"Yuen","year":"2021","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib181","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13024-024-00753-5","article-title":"Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer\u2019s disease","volume":"19","author":"Zeng","year":"2024","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2016.06.030","article-title":"Neurofilament light: A dynamic cross-disease fluid biomarker for neurodegeneration","volume":"91","author":"Zetterberg","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2026.08.009_bib183","article-title":"The exploration of using plasma biomarkers of p-tau217 and p-tau181 for screening Alzheimer\u2019s disease in very elderly people","volume":"16","author":"Zhang","year":"2025","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.009_bib184","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12014-026-09585-5","article-title":"Protein corona proteomics characterizes low-abundance plasma protein signatures and highlights ferroptosis-associated signals in uremic hemodialysis patients","volume":"23","author":"Zhou","year":"2026","journal-title":"Clinical Proteomics"}],"container-title":["International Review of Neurobiology","Blood-Based Biomarkers for Alzheimers and Parkinsons Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:21:53Z","timestamp":1790266913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443472169"],"references-count":184,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.08.009","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}